tosyllysine chloromethyl ketone and Cancer of Prostate

tosyllysine chloromethyl ketone has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edsall, LC; Gelmann, EP; Kimura, K; Markowski, M; Spiegel, S1
Gelmann, EP; Kimura, K1

Other Studies

2 other study(ies) available for tosyllysine chloromethyl ketone and Cancer of Prostate

ArticleYear
Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells.
    Cell death and differentiation, 2003, Volume: 10, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Ceramides; Drug Synergism; Enzyme Activation; Humans; Male; Prostatic Neoplasms; Serine Proteinase Inhibitors; Sphingomyelin Phosphodiesterase; Sphingosine; Tosyllysine Chloromethyl Ketone; Tumor Necrosis Factor-alpha

2003
Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.
    The Journal of biological chemistry, 2000, Mar-24, Volume: 275, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Amino Acid Chloromethyl Ketones; Antigens, CD; Apoptosis; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Drug Synergism; Enzyme Activation; fas Receptor; Fas-Associated Death Domain Protein; Gamma Rays; Humans; Ligands; Male; Prostatic Neoplasms; Radiation Tolerance; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tosyllysine Chloromethyl Ketone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2000